228 related articles for article (PubMed ID: 10960454)
1. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees.
Eren R; Ilan E; Nussbaum O; Lubin I; Terkieltaub D; Arazi Y; Ben-Moshe O; Kitchinzky A; Berr S; Gopher J; Zauberman A; Galun E; Shouval D; Daudi N; Eid A; Jurim O; Magnius LO; Hammas B; Reisner Y; Dagan S
Hepatology; 2000 Sep; 32(3):588-96. PubMed ID: 10960454
[TBL] [Abstract][Full Text] [Related]
2. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
Ilan E; Burakova T; Dagan S; Nussbaum O; Lubin I; Eren R; Ben-Moshe O; Arazi J; Berr S; Neville L; Yuen L; Mansour TS; Gillard J; Eid A; Jurim O; Shouval D; Reisner Y; Galun E
Hepatology; 1999 Feb; 29(2):553-62. PubMed ID: 9918935
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
[TBL] [Abstract][Full Text] [Related]
4. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Morrey JD; Korba BE; Sidwell RW
Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic antibodies against viral hepatitis.
Dagan S; Eren R
Curr Opin Mol Ther; 2003 Apr; 5(2):148-55. PubMed ID: 12772504
[TBL] [Abstract][Full Text] [Related]
7. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
9. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus genetic diversity.
Echevarría JM; Avellón A
J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
[TBL] [Abstract][Full Text] [Related]
12. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
[TBL] [Abstract][Full Text] [Related]
13. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
15. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
16. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
17. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
18. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
